Search research articles
Contact Us
Filters
Showing results (131-140 of 148) with videos related to
Page
of 15
Sort By:
Kidney International
|
January 15, 2022
A prospective cross-sectional study estimated glomerular filtration rate from creatinine and cystatin C in adults with solid tumors
Verônica T Costa E Silva, Luiz A Gil, Lesley A Inker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 25, 2023
A Prospective Cross-Sectional Study on the Performance of the 2021 CKD-EPI Equations Without Race in a Multiracial Population of Adults With Solid Tumors in Brazil
Verônica T Costa E Silva, Luiz A Gil, Lesley A Inker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 27, 2024
Glomerular Filtration Rate Estimation Using β<sub>2</sub>-Microglobulin and β-Trace Protein in Adults With Solid Tumors: A Prospective Cross-Sectional Study
Verônica T Costa E Silva, Luiz A Gil, Lesley A Inker, et al.
Lancet (London, England)
|
March 18, 2015
International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology
Ravindra L Mehta, Jorge Cerdá, Emmanuel A Burdmann, et al.
Diabetes, Obesity & Metabolism
|
January 24, 2019
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
David M Charytan, Scott D Solomon, Peter Ivanovich, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 9, 2009
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Marc A Pfeffer, Emmanuel A Burdmann, Chao-Yin Chen, et al.
The New England Journal of Medicine
|
November 3, 2009
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Marc A Pfeffer, Emmanuel A Burdmann, Chao-Yin Chen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 23, 2018
Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Finnian R Mc Causland, Brian Claggett, Emmanuel A Burdmann, et al.
Plos Medicine
|
January 14, 2021
Recognition and management of community-acquired acute kidney injury in low-resource settings in the ISN 0by25 trial: A multi-country feasibility study
Etienne Macedo, Ulla Hemmila, Sanjib Kumar Sharma, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 28, 2012
Extracorporeal treatment for thallium poisoning: recommendations from the EXTRIP Workgroup
Marc Ghannoum, Thomas D Nolin, David S Goldfarb, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 148) with videos related to
Sort By:
Page
of 15
Kidney International
|
January 15, 2022
A prospective cross-sectional study estimated glomerular filtration rate from creatinine and cystatin C in adults with solid tumors
Verônica T Costa E Silva, Luiz A Gil, Lesley A Inker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 25, 2023
A Prospective Cross-Sectional Study on the Performance of the 2021 CKD-EPI Equations Without Race in a Multiracial Population of Adults With Solid Tumors in Brazil
Verônica T Costa E Silva, Luiz A Gil, Lesley A Inker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 27, 2024
Glomerular Filtration Rate Estimation Using β<sub>2</sub>-Microglobulin and β-Trace Protein in Adults With Solid Tumors: A Prospective Cross-Sectional Study
Verônica T Costa E Silva, Luiz A Gil, Lesley A Inker, et al.
Lancet (London, England)
|
March 18, 2015
International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology
Ravindra L Mehta, Jorge Cerdá, Emmanuel A Burdmann, et al.
Diabetes, Obesity & Metabolism
|
January 24, 2019
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
David M Charytan, Scott D Solomon, Peter Ivanovich, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 9, 2009
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Marc A Pfeffer, Emmanuel A Burdmann, Chao-Yin Chen, et al.
The New England Journal of Medicine
|
November 3, 2009
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Marc A Pfeffer, Emmanuel A Burdmann, Chao-Yin Chen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 23, 2018
Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Finnian R Mc Causland, Brian Claggett, Emmanuel A Burdmann, et al.
Plos Medicine
|
January 14, 2021
Recognition and management of community-acquired acute kidney injury in low-resource settings in the ISN 0by25 trial: A multi-country feasibility study
Etienne Macedo, Ulla Hemmila, Sanjib Kumar Sharma, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 28, 2012
Extracorporeal treatment for thallium poisoning: recommendations from the EXTRIP Workgroup
Marc Ghannoum, Thomas D Nolin, David S Goldfarb, et al.
Page
of 15